WST
West Pharmaceutical·NYSE
--
--(--)
--
--(--)
6.70 / 10
Outperform
Analyst sentiment is split: one Buy and one Neutral, yielding a weighted rating of 5.47. Fund‑flow score is 7.93 (good), with modest overall inflow (~48%) but a negative trend, while small‑cap inflows are positive. Overall outlook modestly optimistic.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-03
InstitutionEvercore ISI Group
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for WST?
- WST holds a Bullish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.70/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
